Current status on the change of glaucoma as the first irreversible blinding disease
Journal Title: Eye Science (Yanke Xuebao) - Year 2021, Vol 36, Issue 6
Abstract
Glaucoma not only is common, but also seriously damages the visual function of the patients, and is recognized as the first irreversible blinding disease in the world. After careful observation, we recognize that untimely diagnosis, unreasonable treatment and irregular follow-up are leading causes to blindness. Opportunistic screening is a main measure to early find the glaucoma in clinical practice. To improve the screening efficiency, the high-risk mass of glaucoma, such as immediate family members of glaucoma patients, older adults and high myopia should be closely focused. In addition, the ophthalmologists should understand the whole process of glaucoma. The development of the primary angle closure glaucoma or primary open angle glaucoma is a concept of continuum. We should make the diagnosis of glaucoma before the patients have any symptoms or serious damage of the visual function. Reasonable treatment should include controlling intraocular pressure in the scope of the target pressure adopting to the optic damage and visual field defect in that eye by drugs, laser or surgery, and as far as possible to improve the drug compliance. Sustained control of glaucoma management depends on the ability to assess the effect of treatment, and to find the instability of the disease and the appropriate management. Glaucoma is a preventable and treatable eye disease. We can decrease the blinding rate and change the current status of the first blinding eye disease for glaucoma.
Authors and Affiliations
Jialiang ZHAO
Keywords
Related Articles
- EP ID EP763516
- DOI 10.3978/j.issn.1000-4432.2021.06.08
- Views 10
- Downloads 0
Experience in the treatment of a case of complex corneal blindness
Keratoconus is a common disease in ophthalmology and treatment is mainly based on etiology. Untreated corneal diseases can develop into corneal clouding, corneal macula, corneal leukoplakia or even loss of vision. This i...
Progress on the treatment of advanced keratoconus with bowman layer Inlay and Onlay transplantation
With the continuous advancement of corneal disease treatment technology, Bowman layer transplantation (including Inlay and Onlay technology) has become an important means for the treatment of advanced progressive keratoc...
Management experience of multicenter clinical trial in ophthalmology
Because of the limitation of single-center clinical trials, more researchers attach importance to multicenter clinical trials. Only 6 multicenter clinical trials were registered on Chinese Clinical Trials Registry Center...
Advances in the treatment of retinal vein occlusion with Faricimab intravitreal injection
Retinal vein occlusion (RVO) is one of the leading retinal diseases causing vision impairment and is often associated with retinal ischemia, hemorrhage, fluid leakage, and macular edema, ultimately resulting in decreased...
“Eye and artificial intelligence” ushers in a new step of challenge of the times
The application of artificial intelligence technology in ophthalmology has been on the agenda, and has continued to progress in practice, such as the application of big data, image information analysis, the era of roboti...